Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 601-625 of 949 matching filings.

Per page
25
Current page
25
3

FORM 3

Filing date
22 Aug 2014
Reporting date
12 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
11 Aug 2014
Reporting date
06 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
21 Jul 2014
Reporting date
17 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
16 Jul 2014
Reporting date
15 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35076

AUTO-GENERATED PAPER DOCUMENT

Filing date
17 Jun 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
16 Jun 2014
Reporting date
13 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35076

DEFINITIVE ADDITIONAL MATERIALS

Filing date
06 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35076

DEFINITIVE PROXY STATEMENT

Filing date
06 Jun 2014
Reporting date
17 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jun 2014
Reporting date
01 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
02 Jun 2014
Reporting date
30 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-35076

SPECIALIZED DISCLOSURE REPORT

Filing date
02 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-195806

EFFECT filing

Filing date
28 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-195806

AMENDMENT TO FORM S-3

Filing date
23 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
19 May 2014
Reporting date
15 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 May 2014
Reporting date
09 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-195806

FORM S-3

Filing date
08 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
07 May 2014
Reporting date
07 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
24 Apr 2014
Reporting date
21 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .